Clinical Trial

Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery

Study acronym: InsuLearn-SMA
Completed
View on ClinicalTrials.gov →
Summary
To evaluate the safety and feasibility of a novel self-learning bolus calculator along with simplified meal announcement (AID+InsuLearn-SMA) in adolescents and young adults with T1D using Automated Insulin Delivery.
Protocol Amendment History 5 changes
critical Trial completed 2026-05-12
notable Enrollment reduced: 6 -> 2 participants 2026-05-12
notable Sponsor changed: Anas El Fathi -> Melissa J. Schoelwer 2026-05-12
notable Primary completion moved earlier: 2026-11-30 -> 2026-04-14 2026-05-12
minor Completion moved earlier: 2026-12-31 -> 2026-04-15 2026-05-12
Trial Details
NCT Number NCT07212179
Lead Sponsor Melissa J. Schoelwer
Conditions Type 1 Diabetes
Enrollment 2 participants
Start Date 2026-03-03
Primary Completion 2026-04-14 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-11